ArticleVaccines2022

A Recombinant Chimeric Protein-Based Vaccine Containing T-Cell Epitopes from Amastigote Proteins and Combined with Distinct Adjuvants, Induces Immunogenicity and Protection against

Daniela P Lage et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.